The ICS Board of Trustees are pleased to announce a group position statement on the use of vaginal mesh for surgical treatment of stress urinary incontinence. We support the use of mid-urethral slings, including synthetic polypropylene mesh slings, for the surgical treatment of SUI.
This statement from ICS is in conjunction with The American Urological Association (AUA), the American Congress of Obstetricians and Gynecologists (ACOG), the American Urogynecologic Society (AUGS), the International Urogynecological Association (IUGA), the Society of Gynecologic Surgeons (SGS) and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU). Who collectively represent more than 84,000 urologists, gynecologists and other healthcare professionals that provide care to women with stress urinary incontinence (SUI).
Synthetic polypropylene mesh sling placement is the most common surgery performed for SUI, and is recognised in clinical practice guidelines as a standard of care for this condition.
To download a copy of this statement please click here.
For more information regarding the groups’ positions, see:
American Urological Association (AUA) Position Statement on the Use of Vaginal Mesh for the Surgical Treatment of Stress Urinary Incontinence
American Urogynecologic Society (AUGS) and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) Position Statement on Mesh Midurethal Slings for Stress Urinary Incontinence
Patients should be appropriately counseled regarding this surgical procedure and potential complications associated with the use of these devices.